Rhonda Farnum is VP at Theravance Biopharma, Inc. (TBPH). They have made 1 open-market trade across 1 company since 2022, most recently 2026-09-15.
CIK 0001898490
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TBPH | 213,476 | $3.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBPH | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $17.03 | $227K | N/A | — | — |
| TBPH | SELL · 10b5-1 | 2026-06-15 | 2026-06-17 | $16.39 | $218K | +1.9% | +1.4% | +2.1% |
| TBPH | SELL · 10b5-1 | 2026-03-16 | 2026-03-18 | $13.95 | $650K | +12.0% | +26.5% | +22.6% |
| TBPH | SELL · 10b5-1 | 2025-12-03 | 2025-12-05 | $18.75 | $1.2M | -4.2% | -1.5% | -27.4% |
| TBPH | SELL · 10b5-1 | 2025-07-14 | 2025-07-16 | $11.39 | $174K | -4.7% | +13.3% | +19.3% |
| TBPH | SELL · 10b5-1 | 2025-06-02 | 2025-06-04 | $11.00 | $264K | -1.8% | +3.3% | +26.4% |
| TBPH | SELL · 10b5-1 | 2025-04-21 | 2025-04-23 | $9.00 | $36K | +9.1% | -1.4% | +19.1% |
| TBPH | SELL · 10b5-1 | 2025-01-21 | 2025-01-23 | $9.00 | $36K | -2.3% | -8.2% | -2.1% |
| TBPH | SELL · 10b5-1 | 2024-11-11 | 2024-11-13 | $9.00 | $36K | -2.1% | +2.2% | -6.5% |
| TBPH | SELL · 10b5-1 | 2024-07-10 | 2024-07-12 | $9.00 | $36K | +6.3% | -12.4% | -14.3% |
| TBPH | SELL · 10b5-1 | 2024-02-22 | 2024-02-22 | $8.71 | $11K | +0.0% | +1.0% | +3.6% |
| TBPH | SELL · 10b5-1 | 2023-11-21 | 2023-11-22 | $10.29 | $14K | +3.2% | +6.6% | -13.9% |
| TBPH | SELL · 10b5-1 | 2023-08-22 | 2023-08-24 | $9.47 | $17K | +0.7% | -1.2% | +9.4% |
| TBPH | SELL · 10b5-1 | 2023-06-08 | 2023-06-12 | $11.13 | $20K | +2.2% | -5.4% | -3.9% |
| TBPH | SELL | 2023-03-09 | 2023-03-13 | $10.20 | $41K | +0.1% | +11.6% | +2.1% |
| TBPH | SELL · 10b5-1 | 2022-05-23 | 2022-05-24 | $8.93 | $10K | -0.7% | -2.3% | +0.3% |
| TBPH | SELL · 10b5-1 | 2022-02-28 | 2022-03-02 | $10.16 | $24K | -9.7% | -7.3% | -13.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.